| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥6.67B | +91.3% |
| Gross profit | ¥2.58B | — |
| Operating income | ¥1.94B | — |
| Net income | ¥1.65B | +1017.8% |
| Gross margin | 38.7% | Net margin 24.7% |
| Revenue Q/Q | +14.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.09B | 61.3% |
| R&D | ¥0.28B | 4.3% |
| SG&A | ¥0.28B | 4.2% |
| Tax & other | ¥0.29B | 4.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
牧原股份 ・ 国信证券 ・ 英维克 ・ 深南电路 ・ 德赛西威 ・ 鹏鼎控股 ・ 中国广核 ・ 亿纬锂能 ・ 爱尔眼科 ・ 同花顺 ・ 东方财富 ・ 智飞生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies